VEGF B cell peptide vaccine (Imugene)

N/A

Report date: 2025/03/20 09:31:33

Base Information

Drug NameVEGF B cell peptide vaccine (Imugene)
Drug Alias NameVEGF peptide vaccine (Ohio State University)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionVascular endothelial growth factor receptor modulators
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State University
China Registration ClassN/A

Develop Information

Active CompaniesImugene Ltd
Inactive CompaniesThe Ohio State University
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A